Answers are grounded in this paper and cite their sources.
Metformin is the first-choice drug for patients with Type 2 diabetes, and this therapy is characterized by being weight neutral. However, in the elderly an additional unintentional weight loss could be considered as an adverse effect of the treatment.
No takes yet. Share an insight, caveat, or question.
Solymár et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: